'Goldmine' U.K. study may hint why Israel has had a larger issue with waning vaccine protection
A "goldmine" of data published by Public Health England on Tuesday provides a look at who may need COVID-19 booster shots, the Financial Times' John Burn-Murdoch reports.
Breaking down the numbers in a series of charts, Burn-Murdoch explains that both the Pfizer-BioNTech and AstraZeneca vaccines, which are the predominant shots in the United Kingdom, have generally held up well against symptomatic coronavirus infections, hospitalizations, and deaths even as the Delta variant took over. There are indications of waning immunity over time, though the declines are more significant among older people and especially older people with underlying health conditions.
That left Burn-Murdoch with two major takeaways. The study simultaneously suggests that "not everyone needs a booster" and that an extra dose "could make a big difference" for those with comorbidities.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
That idea seems to contrast with what's happening in Israel. The country is encouraging everyone regardless of additional factors, to get a third dose of the Pfizer vaccine (and they're even preparing for the possibility of a fourth) because of more drastic signs of waning immunity. But Burn-Murdoch argues the new data backs up the theory that a longer interval between doses deployed by the U.K. sets the stage for better long-term protection than the shorter break taken by Israel and the United States.
The good news is that Israel's booster campaign is working well, so it's worth keeping an eye on what that says about maximizing vaccine efficacy going forward.
-
A running list of US interventions in Latin America and the Caribbean after World War IIin depth Nicolás Maduro isn’t the first regional leader to be toppled directly or indirectly by the US
-
How to rekindle a reading habitThe Week Recommends Fall in love with reading again, or start a brand new relationship with it
-
Political cartoons for January 8Cartoons Thursday’s political cartoons include a well-done steak, a silenced protester, and more
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
A fentanyl vaccine may be on the horizonUnder the radar Taking a serious jab at the opioid epidemic
-
Health: Will Kennedy dismantle U.S. immunization policy?Feature ‘America’s vaccine playbook is being rewritten by people who don’t believe in them’
-
How dangerous is the ‘K’ strain super-flu?The Explainer Surge in cases of new variant H3N2 flu in UK and around the world
-
Vaccine critic quietly named CDC’s No. 2 officialSpeed Read Dr. Ralph Abraham joins another prominent vaccine critic, HHS Secretary Robert F. Kennedy Jr.
-
This flu season could be worse than usualIn the spotlight A new subvariant is infecting several countries
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
Why are autism rates increasing?The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
